InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories

IDXX Clue Score66
United States Fiscal year ends December CIK 0000874716 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

40
Insider
Date
Role
Action
Shares
Price
Amount
Andrew Emerson
20 Aug 2026
EVP, CFO and Treasurer
Exercised, kept
265
$178.26
$47.24K
Sharon E. Underberg
3 Mar 2026
EVP, GC & Corporate Secretary
Exercised, kept
197
$505.53
$99.59K
Jonathan Jay Mazelsky
27 Feb 2026
President and CEO
Exercised, kept
197
$505.53
$99.59K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
197
$505.53
$99.59K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
183
$544.08
$99.57K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
483
$206.94
$99.95K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
817
$178.26
$145.64K
Michael G Erickson
19 Feb 2026
Executive Vice President
Exercised, kept
719
$141.60
$101.81K
George Fennell
9 Feb 2026
Executive Vice President
Exercised, kept
1,476
$67.85
$100.15K
Sharon E. Underberg
12 Aug 2025
EVP, GC & Corporate Secretary
Exercised, kept
183
$544.08
$99.57K
Nimrata Hunt
12 Aug 2025
Executive Vice President
Exercised, kept
183
$544.08
$99.57K
Nimrata Hunt
12 Aug 2025
Executive Vice President
Exercised, kept
483
$206.94
$99.95K
Nimrata Hunt
12 Aug 2025
Executive Vice President
Exercised, kept
560
$178.26
$99.83K
Jonathan Jay Mazelsky
8 Aug 2025
President and CEO
Exercised, kept
183
$598.49
$109.52K
Andrew Emerson
7 Aug 2025
EVP, CFO and Treasurer
Exercised, kept
1,849
$141.60
$261.82K
Michael G Erickson
11 Feb 2025
Executive Vice President
Exercised, kept
1,544
$67.85
$104.76K
George Fennell
7 Feb 2025
Executive Vice President
Exercised, kept
1,256
$79.54
$99.90K
Jonathan Jay Mazelsky
21 Feb 2024
President and CEO
Exercised, kept
483
$206.94
$99.95K
Sharon E. Underberg
16 Feb 2024
EVP, GC & Corporate Secretary
Exercised, kept
483
$206.94
$99.95K
Brian P McKeon
15 Feb 2024
EVP, CFO and Treasurer
Exercised, kept
483
$206.94
$99.95K
Michael Lane
7 Nov 2023
Executive Vice President
Exercised, kept
560
$178.26
$99.83K
Michael Lane
7 Nov 2023
Executive Vice President
Exercised, kept
706
$141.60
$99.97K
Michael Lane
7 Nov 2023
Executive Vice President
Exercised, kept
462
$67.85
$31.35K
Jonathan W Ayers
10 May 2023
Director
Exercised, kept
560
$178.26
$99.83K
Brian P McKeon
5 May 2023
EVP, CFO and Treasurer
Exercised, kept
560
$178.26
$99.83K
Sharon E. Underberg
5 May 2023
EVP, GC & Corporate Secretary
Exercised, kept
483
$206.94
$99.95K
Jonathan Jay Mazelsky
4 May 2023
President and CEO
Exercised, kept
560
$178.26
$99.83K
Nimrata Hunt
9 Feb 2023
Executive Vice President
Exercised, kept
706
$141.60
$99.97K
Jonathan Jay Mazelsky
20 May 2022
President & CEO
Exercised, kept
706
$141.60
$99.97K
Giovani Twigge
23 Feb 2022
Senior Vice President
Exercised, kept
1,893
$288.78
$546.66K
Giovani Twigge
23 Feb 2022
Senior Vice President
Exercised, kept
706
$141.60
$99.97K
Jonathan W Ayers
18 Feb 2022
Director
Exercised, kept
706
$141.60
$99.97K
Kathy Turner V
18 Feb 2022
Senior Vice President
Exercised, kept
706
$141.60
$99.97K
Kathy Turner V
18 Feb 2022
Senior Vice President
Exercised, kept
1,474
$67.85
$100.01K
Sharon E. Underberg
17 Feb 2022
EVP, GC & Corp. Secretary
Exercised, kept
483
$206.94
$99.95K
Brian P McKeon
16 Feb 2022
Executive VP & CFO
Exercised, kept
706
$141.60
$99.97K
Bruce L. Claflin
11 Oct 2021
Director
Exercised, kept
1,921
$160.28
$307.90K
Kathy Turner V
31 Aug 2021
Senior Vice President
Exercised, kept
1,256
$79.54
$99.90K
Nimrata Hunt
10 Aug 2021
Executive Vice President
Exercised, kept
337
$141.60
$47.72K
Nimrata Hunt
10 Aug 2021
Executive Vice President
Exercised, kept
769
$67.85
$52.18K
Showing 250 of 739 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 566
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 473
Sales at will 184
Transactions with no price 0
Shares from compensation/vesting 5,006,061
Sales filed before the plan box existed 165
History held since 1 Nov 2006